Merck

European shares recovered from early losses to end Monday higher as gains in healthcare stocks helped head off weakness in trade-sensitive sectors suc(...)

Congo’s Ebola epidemic is expected to continue spreading though the country’s east, where it has killed 1,000 since August and sparked mistrust and fr(...)

MONDAY Results: Trinity Biotech, Alphabet, McDonald’s, Spotify. Indicators: Irish retail sales (March); euro zone loan growth and money supply (Ma(...)

A website detailing funding provided by the pharmaceutical industry to Irish doctors is back online after being taken down as a potential “compromise”(...)

Drug companies have urged European Union governments not to close the door to medicines and medical devices approved in the UK in the event of a hard(...)

Ten new medicines approved for use by the Health Service Executive last week have been waiting for more than two years on average for sanction, accord(...)

Roche is buying US-based gene therapy specialist Spark Therapeutics for $4.3 billion (€3.78 billion) after developments in this area convinced the Swi(...)

Drug giant MSD has applied for planning permission for a major expansion of its Carlow manufacturing plant. The company, which trades as Merck in the(...)

European shares bounced back on Monday as new-found optimism among investors about the new round of trade talks between Beijing and Washington lifted (...)

Merck’s cancer immumotherapy Keytruda booked sales of more than $2 billion in a quarter for the first time, exceeding Wall Street’s lofty estimates an(...)